Effects of Modified Otago Exercises in Individuals With Diabetic Neuropathy
NCT ID: NCT05691738
Last Updated: 2025-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
38 participants
INTERVENTIONAL
2022-12-23
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Foot and Ankle Exercise on Pain and Quality of Life in Patients With Diabetic Neuropathy
NCT05670600
Effectiveness of Foot Exercise People With Type 2 Diabetes
NCT04064996
The Effects of Different Exercises on Tissue Mechanics, Strength and Neuropathy Symptoms in Type 2 Diabetes Patients
NCT05422235
The Effect of the Physiotherapy Program for Diabetic Individuals on Dexterity, Proprioception, and Functionality
NCT05974878
Effect of Sensory Training on Functional Performance, Balance, Gait in Type 2 Diabetic Individuals With Neuropathy
NCT06979401
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise Group
Information will be given about diabetes and its complications.Modified Otago Exercise will be applied by the physiotherapist.Participants will be given a home program
Exercise Group
The exercise group will be informed about diabetes and diabetes complications. A total of 16 sessions of 8 weeks, modified otago exercises will be applied individually by the research physiotherapist.Individuals will be allowed to walk at a moderate pace for at least 30 minutes 5 days a week (home program).
Control Group
Information will be given about diabetes and its complications.Participants will be given a home program
Control Group
The control group will be informed about diabetes and diabetes complications. Individuals will be allowed to walk at a moderate pace for at least 30 minutes 5 days a week (home program)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise Group
The exercise group will be informed about diabetes and diabetes complications. A total of 16 sessions of 8 weeks, modified otago exercises will be applied individually by the research physiotherapist.Individuals will be allowed to walk at a moderate pace for at least 30 minutes 5 days a week (home program).
Control Group
The control group will be informed about diabetes and diabetes complications. Individuals will be allowed to walk at a moderate pace for at least 30 minutes 5 days a week (home program)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cooperative, able to take instructions (Mini Mental Test score of 24 and above)
* Able to walk independently
* With a Body Mass Index Below 40 Kg/M2
* Not Doing Regular Physical Activity for the Last 6 Months
* Voluntarily participated in the research
Exclusion Criteria
* Any orthopedic or systemic problems that will prevent him from performing the exercises
* The presence of pathology related to the lower limb that occurred within the last 6 months (surgery, fracture, soft tissue injuries, etc.)
* Pregnant
* Vision problem that cannot be corrected with glasses or lenses
* Hearing loss that cannot be corrected with hearing aids
* Foot ulcer
* Patients who have been diagnosed with cancer and are receiving chemotherapy in this context
* With limitation of the range of motion of the joints of the lower extremities
40 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karamanoğlu Mehmetbey University
OTHER
Ankara Yildirim Beyazıt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ali CEYLAN
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ALİ CEYLAN, MSc
Role: PRINCIPAL_INVESTIGATOR
Karamanoğlu Mehmetbey University
Ertuğrul DEMİRDEL, PhD
Role: STUDY_CHAIR
Ankara Yildirim Beyazıt University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karaman Provincial Health Directorate Karaman Training and Research Hospital
Karaman, Center, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KMU-ACEYLAN-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.